↓ Skip to main content

Dove Medical Press

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Overview of attention for article published in OncoTargets and therapy, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
5 patents

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
129 Mendeley
Title
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
Published in
OncoTargets and therapy, November 2013
DOI 10.2147/ott.s50838
Pubmed ID
Authors

Chun Wai Mai, Yew Beng Kang, Mallikarjuna Rao Pichika

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
United States 1 <1%
Austria 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 17%
Student > Master 18 14%
Researcher 17 13%
Student > Bachelor 15 12%
Student > Doctoral Student 10 8%
Other 21 16%
Unknown 26 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 31 24%
Medicine and Dentistry 27 21%
Biochemistry, Genetics and Molecular Biology 20 16%
Immunology and Microbiology 5 4%
Chemistry 5 4%
Other 13 10%
Unknown 28 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2021.
All research outputs
#8,882,501
of 26,017,215 outputs
Outputs from OncoTargets and therapy
#587
of 3,040 outputs
Outputs of similar age
#80,549
of 230,986 outputs
Outputs of similar age from OncoTargets and therapy
#11
of 28 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,040 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,986 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.